Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Auspherix Ltd.
Dr Neil Miller, the recently-appointed CEO of UK-based biotech Auspherix, talks to Scrip about the company's new class of antibiotics and how it plans to help address the worldwide antimicrobial resistance crisis.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June 2015.
Brief profiles of these recently formed companies: Auspherix, Medella Health, OmniSeq, and Xtuit Pharmaceuticals.